V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10095141 | 10054804 | 1.9 | 71.25 | null | 2017-12-08 | 2017-12-12 | Bendamustine+Rituximab(Sub Courses) | 02 | null | BENDAMUSTINE + RITUXIMAB | 101444856 |
| 10095676 | 10054805 | 1.69 | 58.45 | Adjuvant (A) | 2019-06-09 | 2019-07-03 | Venetoclax | 02 | N | VENETOCLAX | 100489900 |
| 10097425 | 10054806 | 1.71 | 68.75 | null | 2022-02-03 | 2022-02-13 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100448750 |
| 10097510 | 10054807 | 1.72 | 114 | 03 | null | 2018-04-15 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101073045 |
| 10097910 | 10054808 | 1.65 | 73.2 | 02 | 2021-05-10 | 2021-05-20 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 101086136 |
| 10098347 | 10054809 | 1.67 | 56 | Palliative (P) | 2021-01-18 | 2021-07-13 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100692051 |
| 10098353 | 10054810 | 1.84 | 67 | null | null | 2021-11-26 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 101239963 |
| 10099479 | 10054811 | 1.77 | 45.8 | null | null | 2022-04-15 | FLUOROURACIL + OXALIPLATIN | 02 | null | FLUOROURACIL + OXALIPLATIN | 100222188 |
| 10100653 | 10054812 | 1.61 | 71.7 | null | 2019-05-08 | 2019-05-20 | Avelumab | 02 | null | DARATUMUMAB | 101035928 |
| 10101336 | 10054814 | 1.86 | 79.5 | 03 | 2021-09-14 | 2021-09-21 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 100707582 |
| 10102796 | 10054815 | 1.84 | 75 | 03 | 2016-10-08 | 2019-02-01 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100157101 |
| 10102958 | 10054816 | 1.81 | 79.5 | Palliative (P) | 2021-09-01 | 2021-10-12 | DARATUMUMAB | 02 | null | NIVOLUMAB | 101538390 |
| 10103476 | 10054817 | 0 | 69 | null | 2015-05-16 | 2015-08-25 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 100440302 |
| 10103666 | 10054818 | 1.71 | 80.4 | Disease modification (D) | null | 2017-01-03 | Avelumab | 02 | null | AVELUMAB | 100985158 |
| 10103791 | 10054819 | 1.78 | 56 | Palliative (P) | 2019-11-23 | 2019-11-27 | Avelumab | 02 | N | RUXOLITINIB | 100036702 |
| 10104332 | 10054820 | 1.67 | 54 | 03 | 2021-06-01 | 2021-06-22 | Avelumab | 02 | N | AVELUMAB | 101266614 |
| 10104406 | 10054821 | null | 53 | 03 | 2021-03-27 | 2021-10-11 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101373821 |
| 10105330 | 10054822 | null | 83.25 | Disease modification (D) | null | 2020-01-15 | DARATUMUMAB | 02 | null | NIVOLUMAB | 101353414 |
| 10105476 | 10054823 | 1.76 | 47.2 | Adjuvant (A) | 2018-05-06 | 2018-05-15 | Avelumab | 02 | N | VENETOCLAX | 100594114 |
| 10105766 | 10054824 | 1.75 | 0 | Palliative (P) | 2018-06-30 | 2019-01-18 | Avelumab | 02 | N | AVELUMAB | 100669035 |
| 10106203 | 10054825 | 1.67 | 63 | Curative (C) | 2018-04-01 | 2018-04-01 | RUXOLITINIB | 02 | null | RUXOLITINIB | 100263461 |
| 10106535 | 10054826 | 1.77 | 80.2 | Palliative (P) | null | 2019-06-21 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100437432 |
| 10107180 | 10054827 | 1.83 | 110 | null | 2019-07-21 | 2019-08-10 | DARATUMUMAB | N | null | DARATUMUMAB | 101862311 |
| 10107671 | 10054828 | 1.78 | 82.3 | Palliative (P) | null | 2019-03-04 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 100140242 |
| 10111204 | 10054830 | 1.65 | 91.7 | Adjuvant (A) | 2018-10-29 | 2018-10-29 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 101171373 |
| 10112622 | 10054831 | null | 45.8 | null | 2019-11-28 | 2019-12-12 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100919771 |
| 10113033 | 10054832 | 1.5 | 66.5 | null | 2018-02-18 | 2018-03-04 | Venetoclax | 02 | null | VENETOCLAX | 100409317 |
| 10113605 | 10054833 | 1.88 | 67.4 | Palliative (P) | 2021-08-28 | 2021-08-28 | BENDAMUSTINE + RITUXIMAB | 02 | N | BENDAMUSTINE + RITUXIMAB | 100532609 |
| 10114001 | 10054834 | 1.85 | 57 | Palliative (P) | 2020-08-17 | 2020-08-31 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 100067123 |
| 10114484 | 10054835 | 1.88 | 68.7 | Disease modification (D) | 2019-07-12 | 2019-07-20 | Avelumab | 02 | N | RUXOLITINIB | 100430739 |
| 10115991 | 10054836 | 1.77 | 0 | 03 | 2018-12-01 | 2019-01-09 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101705842 |
| 10118194 | 10054837 | 1.85 | 89 | null | 2018-11-23 | 2019-04-27 | Avelumab | 02 | null | DARATUMUMAB | 100899876 |
| 10120299 | 10054838 | 1.87 | 76 | Palliative (P) | 2018-01-22 | 2018-01-29 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101833148 |
| 10121867 | 10054839 | null | 0 | null | null | 2019-11-13 | Avelumab | 02 | null | CARBOPLATIN + GEMCITABINE | 101375454 |
| 10121934 | 10054840 | null | 56.2 | 03 | 2019-09-09 | 2020-10-09 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 100117349 |
| 10122835 | 10054841 | 0 | 90.1 | Palliative (P) | 2021-09-17 | 2021-09-19 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100192713 |
| 10123704 | 10054842 | 1.72 | 73.2 | null | 2019-09-02 | 2019-09-12 | RUXOLITINIB | 02 | null | BENDAMUSTINE + RITUXIMAB | 100728530 |
| 10124951 | 10054843 | null | 85.75 | null | 2021-09-13 | 2021-12-23 | Venetoclax | 02 | null | VENETOCLAX | 100266071 |
| 10126275 | 10054844 | 1.65 | 87.6 | null | 2016-03-04 | 2016-06-28 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 101494062 |
| 10126468 | 10054845 | null | 78.6 | Palliative (P) | 2021-03-30 | 2021-04-06 | CEMIPLIMAB | 02 | N | CEMIPLIMAB | 100006212 |
| 10128351 | 10054846 | null | 56.4 | null | 2021-04-28 | 2021-11-27 | Irinotecan + Modified De Gramont | 02 | null | FLUOROURACIL + IRINOTECAN | 100070529 |
| 10128586 | 10054847 | 1.74 | 46.8 | Palliative (P) | 2020-06-19 | 2020-07-03 | CEMIPLIMAB | N | N | CEMIPLIMAB | 100481268 |
| 10131685 | 10054848 | 1.75 | 56 | Palliative (P) | 2018-03-11 | 2018-03-25 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101420687 |
| 10132630 | 10054849 | 1.61 | 67 | Palliative (P) | 2021-01-04 | 2021-05-05 | Avelumab | 02 | N | AVELUMAB | 100174718 |
| 10133018 | 10054850 | 1.84 | 72 | Palliative (P) | 2019-09-01 | 2019-09-15 | Avelumab | 02 | N | FLUOROURACIL + OXALIPLATIN | 101090201 |
| 10133510 | 10054851 | 1.61 | 53.8 | Palliative (P) | 2021-03-19 | 2021-03-19 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100802040 |
| 10135790 | 10054852 | 1.81 | 81.5 | Adjuvant (A) | 2019-02-20 | 2019-03-06 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101571969 |
| 10136421 | 10054853 | 1.75 | 73.2 | 03 | 2017-09-10 | 2017-09-24 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101469627 |
| 10136760 | 10054854 | 1.73 | null | null | 2017-01-25 | 2017-01-25 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 101681809 |
| 10138278 | 10054855 | 1.6 | 0 | Palliative (P) | 2022-03-10 | 2022-05-10 | Avelumab | 02 | Y | CEMIPLIMAB | 100000568 |